Down syndrome: Distribution of brain amyloid in mild cognitive impairment
- PMID: 32435685
- PMCID: PMC7233421
- DOI: 10.1002/dad2.12013
Down syndrome: Distribution of brain amyloid in mild cognitive impairment
Abstract
Introduction: Down syndrome (DS) is associated with a higher risk of dementia. We hypothesize that amyloid beta (Aβ) in specific brain regions differentiates mild cognitive impairment in DS (MCI-DS) and test these hypotheses using cross-sectional and longitudinal data.
Methods: 18F-AV-45 (florbetapir) positron emission tomography (PET) data were collected to analyze amyloid burden in 58 participants clinically classified as cognitively stable (CS) or MCI-DS and 12 longitudinal CS participants.
Results: The study confirmed our hypotheses of increased amyloid in inferior parietal, lateral occipital, and superior frontal regions as the main effects differentiating MCI-DS from the CS groups. The largest annualized amyloid increases in longitudinal CS data were in the rostral middle frontal, superior frontal, superior/middle temporal, and posterior cingulate cortices.
Discussion: This study helps us to understand amyloid in the MCI-DS transitional state between cognitively stable aging and frank dementia in DS. The spatial distribution of Aβ may be a reliable indicator of MCI-DS in DS.
Keywords: ABC‐DS; ADDS; AV‐45; Alzheimer's disease; Down syndrome; MCI; PET; amyloid; dementia.
© 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, Inc. on behalf of the Alzheimer's Association.
Conflict of interest statement
The Co‐Principal Investigators of the ADDS component of the ABC‐DS program are Nicole Schupf, PhD, Doctor of Public Health (DrPh) (Columbia University), Ira Lott, MD, and Wayne Silverman, PhD (UC Irvine). Co‐Principal Investigators of the NiAD ABC‐DS component are Benjamin Handen, PhD and William Klunk, MD, PhD (University of Pittsburgh), and Bradley Christian, PhD (University of Wisconsin‐Madison)
Figures
Similar articles
-
Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1304-14. doi: 10.1007/s00259-016-3359-8. Epub 2016 Mar 22. Eur J Nucl Med Mol Imaging. 2016. PMID: 27003417
-
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334. Brain. 2017. PMID: 28077397 Free PMC article.
-
Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1067-76. doi: 10.1007/s00259-015-3291-3. Epub 2016 Jan 7. Eur J Nucl Med Mol Imaging. 2016. PMID: 26739329
-
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.J Alzheimers Dis. 2019;70(4):1197-1207. doi: 10.3233/JAD-190220. J Alzheimers Dis. 2019. PMID: 31322568
-
Brain amyloid and the transition to dementia in Down syndrome.Alzheimers Dement (Amst). 2020 Nov 11;12(1):e12126. doi: 10.1002/dad2.12126. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 33204814 Free PMC article.
Cited by
-
Abnormal degree centrality and functional connectivity in Down syndrome: A resting-state fMRI study.Int J Clin Health Psychol. 2023 Jan-Apr;23(1):100341. doi: 10.1016/j.ijchp.2022.100341. Epub 2022 Oct 6. Int J Clin Health Psychol. 2023. PMID: 36262644 Free PMC article.
-
Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome.Front Neurosci. 2022 Aug 12;16:954999. doi: 10.3389/fnins.2022.954999. eCollection 2022. Front Neurosci. 2022. PMID: 36033603 Free PMC article. Review.
-
Joint-label fusion brain atlases for dementia research in Down syndrome.Alzheimers Dement (Amst). 2022 May 25;14(1):e12324. doi: 10.1002/dad2.12324. eCollection 2022. Alzheimers Dement (Amst). 2022. PMID: 35634535 Free PMC article.
-
Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.J Alzheimers Dis. 2022;85(1):153-165. doi: 10.3233/JAD-210572. J Alzheimers Dis. 2022. PMID: 34776436 Free PMC article.
-
Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS).BJPsych Open. 2021 Apr 13;7(3):e79. doi: 10.1192/bjo.2021.36. BJPsych Open. 2021. PMID: 33845926 Free PMC article.
References
-
- Heller T, Scott HM, Janicki MP, Pre‐Summit Workgroup on Caregiving and Intellectual/Developmental Disabilities . Caregiving, intellectual disability, and dementia: report of the Summit Workgroup on Caregiving and Intellectual and Developmental Disabilities. Alzheimers Dement. 2018;4:272‐282. - PMC - PubMed
-
- Strydom A, Shooshtari S, Lee L, et al. Dementia in older adults with intellectual disabilities‐epidemiology, presentation, and diagnosis. J Policy Pract Intellect Disabil. 2010;7:96‐110.
-
- Prasher VP, Farrer MJ, Kessling AM, et al. Molecular mapping of Alzheimer‐type dementia in Down's syndrome. Ann Neurol. 1998;43:380‐383. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources